Position
PRUDENTIAL PLC in Neurocrine Biosciences Inc
Back to the book · All holders of NBIX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$40.7K$141.83 → $131.74
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 4.13K | $586.3K | — | — | — | 0.0% |
| Q1 2026 | 4.04K | $531.7K | $131.74 | −$40.7K | −$13.9K | 0.0% |